339 related articles for article (PubMed ID: 25364989)
1. Immunological effects of ayahuasca in humans.
dos Santos RG
J Psychoactive Drugs; 2014; 46(5):383-8. PubMed ID: 25364989
[TBL] [Abstract][Full Text] [Related]
2. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
[TBL] [Abstract][Full Text] [Related]
3. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
4. Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment.
Brierley DI; Davidson C
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):263-72. PubMed ID: 22691716
[TBL] [Abstract][Full Text] [Related]
5. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
6. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
7. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
[TBL] [Abstract][Full Text] [Related]
8. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
[TBL] [Abstract][Full Text] [Related]
9. Health status of ayahuasca users.
Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
[TBL] [Abstract][Full Text] [Related]
10. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
Heise CW; Brooks DE
J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
12. Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience.
Dos Santos RG; Hallak JEC
Epilepsy Behav; 2021 Aug; 121(Pt B):106300. PubMed ID: 31182391
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of ayahuasca administered in two repeated doses.
Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
15. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
[TBL] [Abstract][Full Text] [Related]
16. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
McIlhenny EH; Riba J; Barbanoj MJ; Strassman R; Barker SA
Biomed Chromatogr; 2011 Sep; 25(9):970-84. PubMed ID: 21058415
[TBL] [Abstract][Full Text] [Related]
17. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
Liester MB; Prickett JI
J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
[TBL] [Abstract][Full Text] [Related]
18. [The potential use of ayahuasca in psychiatry].
Frecska E; Bokor P; Andrassy G; Kovacs A
Neuropsychopharmacol Hung; 2016 Jun; 18(2):79-86. PubMed ID: 27390204
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
20. A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions.
dos Santos RG
J Psychoactive Drugs; 2013; 45(2):179-88. PubMed ID: 23909005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
